KWM
PMN icon

Kingsview Wealth Management’s ProMIS Neurosciences PMN Stock Holding History

Kingsview Wealth Management’s Portfolio PMN Stock Details PMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,242
Closed -$15K – 1275
2025
Q2 		$15K Buy
+1,242
New +$16.9K ﹤0.01% 1159
2024
Q1 		– Sell
-444
Closed -$12.8K – 1053
2023
Q4 		$12.8K Buy
+444
New +$16.6K ﹤0.01% 940

Other funds holding PMN

ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
HFS
Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return

Kingsview Wealth Management's PMN Position: Q3 2025 in Review

Kingsview Wealth Management sold out of ProMIS Neurosciences (PMN) in Q3 2025, closing a stake of 1,242 shares — an estimated $15K sold.

Kingsview Wealth Management first reported a position in PMN in Q4 2023 and held it in 2 quarters. The position peaked at $15K in Q2 2025. 23 funds tracked by Wall St. Rank hold PMN as of Q3 2025.

  • Kingsview Wealth Management reported no remaining ProMIS Neurosciences position as of Q3 2025 after selling out during the quarter.
  • Kingsview Wealth Management sold 1,242 ProMIS Neurosciences shares in Q3 2025, an estimated $15K.
  • Kingsview Wealth Management first reported a position in ProMIS Neurosciences in Q4 2023 and held it in 2 quarters.
  • Kingsview Wealth Management's ProMIS Neurosciences position peaked at $15K in Q2 2025.
  • 23 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q3 2025.

Based on Kingsview Wealth Management's 13F filing for Q3 2025, filed 12 Nov 2025.